Beta Drugs Limited Announces 21st AGM on September 30, 2026
Beta Drugs Limited will hold its 21st Annual General Meeting (AGM) on September 30, 2026. The meeting is scheduled for 10:30 a.m. at the company's registered office. The Annual Report for FY 2025-26 will also be submitted.
The announcement of an AGM is a standard procedural event for listed companies and typically has a low impact on the stock price unless significant strategic decisions or financial results are discussed during the meeting.
The announcement is a routine corporate event (AGM) and does not contain any specific financial performance details or forward-looking statements that would indicate a positive or negative sentiment.
Beta Drugs Limited has announced that its 21st Annual General Meeting (AGM) will take place on Wednesday, September 30, 2026, commencing at 10:30 a.m. The meeting will be held at the company's registered office located at Village Nandpur, Lodhimajra Road, Baddi, Distt Solan, Himachal Pradesh 174101.
The company will submit the Notice of the 21st Annual General Meeting and the Annual Report for the Financial Year 2025-26 to the exchange. This submission will occur on or before the date the documents are dispatched to the shareholders.
This intimation is provided for the information and record of the National Stock Exchange of India Limited.
A plain-language summary of a public exchange filing by Beta Drugs Limited. Read the original for the full detail.